Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elismetrep in the Acute Treatment of Migraine
NCT07816367Phase 3Recruiting
- Sponsor
- TriGemX Bio
- Start
- Oct 2026
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
A Phase 3 trial of elismetrep in migraine, sponsored by TriGemX Bio. Started Oct 2026; status: recruiting.
02
Drugs
elismetrep
03
Conditions
migraine
Beyond the preview
Go deeper on NCT07816367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07816367.